On October 21, 2025, HUTCHMED (China) Limited published an announcement regarding the vesting of certain non-performance based awards granted on October 20, 2021, under its Long Term Incentive Plan. According to the announcement, the awards vested on October 20, 2025.
The directors named in the announcement—Non-executive Director Dr. Dan Eldar, Non-executive Director Ms. Edith Shih, and Independent Non-executive Director Professor Tony Mok—each received 1,938 American depositary shares (ADS). For Ms. Shih, the ADS were issued to her employer, Hutchison International Limited. HUTCHMED is a commercial-stage biopharmaceutical company focused on targeted therapies and immunotherapies for cancer and immunological diseases. Further details appear in the official announcement dated October 21, 2025.